|Bid||0.00 x 1100|
|Ask||0.00 x 1100|
|Day's Range||212.69 - 218.67|
|52 Week Range||60.60 - 260.98|
|Beta (3Y Monthly)||-0.16|
|PE Ratio (TTM)||65.46|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||1.92 (0.91%)|
|1y Target Est||229.00|
Hain Celestial (HAIN) is expected to further gain from its Project Terra program and strategic acquisitions amid high expenses and soft U.S. segment sales.
Given that both the United States and China are imposing tit-for-tat tariffs, the trade war is unlikely to end anytime soon.
Medifast Inc., the weight-loss program provider whose shares have tripled this year, was whipsawed Thursday by a short-seller’s report claiming the company hasn’t disclosed contaminants in its supplements. The new short report from Gotham City Research claims that Medifast was aware of elevated levels of lead and other toxic metals in its Optavia product line. Gotham also criticizes the company’s supply chain and aggressive pricing.
Now, when I say Medifast (NYSE:MED) is gaining while its customers are losing, that’s a good thing. You see, MED stock is a weight loss management company. Sure, it’s easy for a small firm with a small market cap to double its business and its stock price.
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
BALTIMORE, Sept. 6, 2018 /PRNewswire/ -- Medifast, Inc. (MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, announced today that its Board of Directors has declared a $0.48 cash dividend to its stockholders. The quarterly cash dividend of $0.48 per share is payable on November 8, 2018 to stockholders of record as of the close of business on September 21, 2018. The Company expects to maintain a program of paying dividends on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the Medifast Board of Directors, who will evaluate the Company's dividend program from time to time based on factors that it deems relevant.
Liquidity indicates a company’s capability of meeting debt obligations by converting assets into liquid cash and equivalents. It considers inventory excluding current assets relative to current liabilities.
Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting
Success in stock market investing comes from intense research and analysis and not from taking leaps in the dark.Source: Shutterstock
Medifast (NYSE:MED) announced Q2 earnings at the beginning of the month and they were stunning. Revenue was up 55% and its flagship Optavia brand brought in 64% of that revenue. Net income was up 86%. Earnings-per-share were up 84%. After those kinds of results, with similarly impressive results for a few quarters now, it’s not too surprising that MED stock is up a whopping 198% year-to-date.
Momentum could be pointing to big gains going forward for these sectors — regardless of how long the S&P takes to break out.
Zacks.com highlights: Medifast, Continental Building Products, Huntsman, Logitech International and Allison Transmission Holdings
Richard Herman Driehaus who is a well-known American businessman and fund manager, developed an investment approach based on the buy high and sell higher rule.